LatticePoint – Where innovation and market access meet
Worldwide expertise
Tailored consulting solutions
We are a consulting firm specialising in pricing and market access for medicines and medical devices — led by former industry market access leaders who understand how to plan for the political, scientific and financial realities pivotal to negotiating product access.
We work with biopharma companies and investors to help define, establish and defend the value of their products in key markets around the world — with multilingual teams based in Switzerland, Spain, Denmark and the United States.
Global negotiation experience
At LatticePoint, we have in-country experience working with, and on behalf of, our clients who require on-the-ground assistance. Our multilingual staff of native German, French, Italian, Spanish, Portuguese and English speakers is experienced at handling negotiations in many key countries while keeping an eye on cross-border implications. We engage with payers, providers, hospitals, HTA bodies and EMA for early access, give feedback on clinical program design, and create and execute in-country reimbursement strategy negotiations in key markets around the world. We retain a Global Payer Panel for market research interviews.
Countries supported worldwide
Therapeutic areas covered
Languages spoken natively